SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences - Quaterly Results

17 May 2023 Evaluate
The March 2023 quarter revenue stood at Rs. 606.96 millions, up 20.79% as compared to Rs. 502.51 millions during the corresponding quarter last year.Good  Net Profit growth of 26.58% reported above the corresponding previous quarter figure of Rs. 49.48 millions to Rs. 62.63 millioins.The company reported a good operating profit of 118.69 millions compared to 111.35 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 606.96 502.51 20.79 2540.00 2193.51 15.80 2540.00 2193.51 15.80
Other Income 9.50 10.81 -12.12 53.23 46.57 14.30 53.23 46.57 14.30
PBIDT 118.69 111.35 6.59 602.09 652.26 -7.69 602.09 652.26 -7.69
Interest 3.48 13.83 -74.84 64.97 24.68 163.25 64.97 24.68 163.25
PBDT 115.21 97.52 18.14 537.12 627.58 -14.41 537.12 627.58 -14.41
Depreciation 26.21 25.48 2.86 97.88 95.02 3.01 97.88 95.02 3.01
PBT 89.00 72.04 23.54 439.24 532.56 -17.52 439.24 532.56 -17.52
TAX 26.37 22.56 16.89 115.82 137.39 -15.70 115.82 137.39 -15.70
Deferred Tax 3.47 2.92 18.84 8.55 -5.14 -266.34 8.55 -5.14 -266.34
PAT 62.63 49.48 26.58 323.42 395.17 -18.16 323.42 395.17 -18.16
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 19.55 22.16 -11.75 23.70 29.74 -20.28 23.70 29.74 -20.28

Hester Biosciences Share Price

2531.25 421.85 (20.00%)
13-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.05
Dr. Reddys Labs. 1234.60
Cipla 1426.80
Zydus Lifesciences 1131.05
Lupin 2497.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: